Freedom of information (FOI) releases from MHRA

This is a disclosure log of Medicines and Healthcare products Regulatory Agency's responses to freedom of information (FOI) or environmental information regulations (EIR) requests that might be of wider public interest.

If you can't find the information you're looking for, you can make a new FOI request.

Filters

Clear filters
  • Keywords filters

  • Year filters

  • Month filters

1,715 disclosures

  1. I wish to have yellow card information for the following LIMS: 1. Clinisys WinPath Enterprise 2. Haemonetics SafeTrace Tx 3. Medi-Tech LIMS 4. LabWare 5. Sussex Biological Bank Manager I would like to receive any yellow cards received for the LIMS above in the last 10 years.

    Published: 25 February 2026

  2. We kindly request a copy of an electronic listing (preferably in CSV format) of all inspections conducted since January 2025. Please include the following fields: case_number inspection_category site_operator number_of_critical_observations number_of_major_observations number_of_other_observations Please also kindly include the fields that were provided in previous responses, such as FOI2025_01125, but not limited to: party_site_id site_name address1 address2 city postal_code country

    Published: 25 February 2026

  3. We wish to request copies of the latest approved Clinical / Non-Clinical / Quality overviews from the following licences: • Vancomycin Morningside Healthcare, 125mg, Capsules, hard, PL 20117/0149 • Vancomycin Wockhardt UK, 500 mg and 1 g, Powder for solution for intravenous infusion / Powder for solution for oral use, PL 29831/0319 and PL 29831/0322

    Published: 25 February 2026

  4. I am looking for the Public Assessment Report from the initial MAA for CitraFleet, PL 43885/0004. The MA was granted on 08 June 2005. Thank you.

    Published: 25 February 2026

  5. Complaints referred to you by the ASA Ref: A25-1317505. 06/11/25 Ref: A25 1317508. 17/11/25

    Published: 25 February 2026

  6. A simple list please of all pharmaceutical agents currently licensed for use in asthma treatment with inhaler delivery.

    Published: 25 February 2026

  7. See attached

    Published: 25 February 2026

  8. Under the Freedom of Information Act (2000) please can I have the following information 1) The list of external clinical experts the MHRA sought advice from in December 2020 regarding the HeartWare (HVAD) device produced by Medtronic. Please also provide a copy of their declarations of interest. 2) All recorded discussions / minutes etc at any Active Implant Devices Meetings from 1 Jan 2018 to the present day relating to the HeartWare (HVAD) device produced by Medtronic. I you require any clarification then please contact me

    Published: 25 February 2026

  9. The meeting was held in DEc 2025 and hosted by MHRA. I would like all meeting content provided to delegates including: The AI aide memoire. All PowerPoint presentations All case study information referenced in the agenda

    Published: 25 February 2026

  10. Dear Sir or Madam, I can't find faricimab (Vabysmo) on the MHRA iDAPs webpage (https://yellowcard.mhra.gov.uk/idaps). I doubt it's because there haven't been any adverse effects. I have found aflibercept and ranibizumab but wish to look at faricimab. Please can you send me the iDAPs report.

    Published: 25 February 2026